Cormedix Inc (CRMD)
7.67 +0.15 (+1.99%) 04/17/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 7.66 -0.01 (-0.13%) 18:11 ET
for Thu, Apr 17th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -17,930 | -46,339 | -29,702 | -28,210 | -22,028 |
Depreciation Amortization | 457 | 206 | 209 | 177 | 162 |
Accounts receivable | -51,791 | N/A | 42 | -44 | -3 |
Accounts payable and accrued liabilities | -2,560 | 2,078 | -7 | 1,082 | 103 |
Other Working Capital | -39,408 | 2,230 | 1,066 | 1,835 | -2,646 |
Other Operating Activity | 60,616 | 3,416 | 4,034 | 4,005 | 2,444 |
Operating Cash Flow | $-50,615 | $-38,410 | $-24,357 | $-21,155 | $-21,968 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 21,346 | -16,734 | -3,490 | -7,710 | 7,539 |
PPE Investments | -116 | -327 | -219 | -1,425 | -113 |
Investing Cash Flow | $21,231 | $-17,062 | $-3,709 | $-9,135 | $7,426 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 26,606 | 56,115 | 17,898 | 41,593 | 40,100 |
Other Financing Activity | -287 | -199 | 0 | 165 | 0 |
Financing Cash Flow | $26,319 | $55,917 | $17,898 | $41,758 | $40,100 |
Exchange Rate Effect | -2 | 3 | -9 | -13 | 13 |
Beginning Cash Position | 43,823 | 43,375 | 53,551 | 42,097 | 16,525 |
End Cash Position | 40,756 | 43,823 | 43,375 | 53,551 | 42,097 |
Net Cash Flow | $-3,067 | $448 | $-10,177 | $11,455 | $25,572 |
Free Cash Flow | |||||
Operating Cash Flow | -50,615 | -38,410 | -24,357 | -21,155 | -21,968 |
Capital Expenditure | -116 | -327 | -219 | -1,425 | -113 |
Free Cash Flow | -50,730 | -38,737 | -24,576 | -22,581 | -22,080 |